MedPath
NMPA Approval

Insulin Glulisine Injection

国药准字SJ20150012

March 5, 2024

S20150012

Drug Information

谷赖胰岛素注射液

艾倍得

注射剂

3ml:300U/预填充笔SoloStar

生物制品

March 5, 2024

March 4, 2029

Company Information

Applicant Company

Industriepark Hoechst, Brueningstrasse 50, D-65926 Frankfurt am Main, Germany

Manufacturing Company

Industriepark Hoechst, Brueningstrasse 50, D-65926 Frankfurt am Main, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

谷赖胰岛素注射液 - NMPA 批准文号 | MedPath